Search results
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parki...
PharmiWeb· 17 hours agoLAS VEGAS, July 2, 2024 (Newswire.com) - GB Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired biopharmaceutical research and development company, has signed a letter of intent outlining ...